Zofran Birth Defect Lawsuit Alleges Drug Caused Supraventricular Tachycardia

November 02, 2015 – – ZofranLegal.com reports on a lawsuit filed by an Oakland, California resident against pharmaceutical manufacturer GlaxoSmithKline and their anti-nausea drug Zofran. The suit alleges that the woman’s son was born with birth defects, specifically supraventricular tachycardia, due to the fact that she used Zofran while the child was developing in utero.

The mother’s complaints, filed under case number R615761042 in the Superior Court of the State of California, explained that she used Zofran during the first trimester of her pregnancy, when much of her son’s development was taking place. The plaintiff alleges that there was no prior familial history of supraventricular tachycardia (SVT). Had she known of the alleged link between Zofran and birth defects, she states that she never would have used the drug for her nausea.

The plaintiff indicated that due to his condition, her son suffers from shortness of breath, shallow breathing, and rapid breathing. He requires a prescription medication to diffuse these symptoms. The lawsuit asks for compensation for medical expenses and pain and suffering that has been endured.

Supraventricular Tachycardia causes the heart to beat at a much faster pace than a normal heart would. Typically, a SVT heart beats about 100 times per minute, versus a healthy heart which beats between 60 and 90. Because this allows little to no relaxation time in between beats for the heart muscle, the unrested chambers are also not able to fill properly and therefore supply the rest of the body with enough oxygenated blood.

Across the U.S., over 60 parents have stepped up with similar allegations against Zofran. The drug was never approved to treat pregnant women, and has been marketed and prescribed “off-label” to these individuals. The U.S. Food and Drug Administration approved the drug to treat individuals suffering from severe nausea and vomiting episodes after undergoing chemotherapy, radiation, or anesthesia.

Individuals who were prescribed Zofran and used the drug while pregnant who then gave birth to babies with defects may be entitled to compensation. The attorneys at Monheit Law are currently working to ensure that anyone in this situation is able to get a free consultation.

For additional information on Zofran or Zofran Birth Defect Lawsuits, please contact Attorney Michael Monheit by calling 877-620-8411.

###

Contact ZofranLegal.com:

Michael Monheit
1-877-620-8411
michael@monheit.com
1368 Barrowdale Road, Rydal, PA 19046

ReleaseID: 60005038